48
D.P. Arnold et al. / Journal of Organometallic Chemistry 607 (2000) 41–50
The toluene was removed under vacuum, and the
residue was triturated three times with ether. Each time
the supernatant was decanted, then the volatiles were
removed under vacuum, leaving the product
PdBr(NiDPP)(PPh3)2 (6) as purple microcrystals. TLC
showed the absence of the starting material. As de-
scribed in the text above, some exchange to form the
chloro analogue occurred in the presence of chlorinated
solvents. This method was also used to prepare
PdBr(H2DPP)(PPh3)2 (7).
FABMS: 1261.0 (MH+ Anal. Calc. 1261.09), MH+ for
chloro complex also observed.
Data for 9: H-NMR: l 6.7 (36H, m, PPh), 7.2 (24H,
m, PPh), 7.6 (6H, m, m-, p-10,20-Ph), 7.83 (4H, dd,
o-10,20-Ph), 8.08, 9.29 (each 2H, d, b-H); 31P-NMR: l
29.0; UV–vis: umax (m/103 M−1 cm−1) 432 (210), 498
(5.4), 538 (18.1), 579 (9.4) mm; FABMS: 1937.9 (M+
Anal. Calc. 1938.10), M+ for bromochloro and
dichloro complexes also observed.
1
1
Data for 6: H-NMR: l 6.6 (18H, m, PPh), 7.2 (12H,
3.3. Syntheses using Pd2(dba)3 and bidentate
m, PPh), 7.6 (6H, m, m-, p-10,20-Ph), 7.91 (4H, dd,
o-10,20-Ph), 8.24, 8.69, 8.94, 9.40 (each 2H, d, b-H),
9.55 (1H, s, meso-H); 31P-NMR: l 29.8 (chloro com-
plex 30.1); UV–vis: umax (m/103 M−1 cm−1) 414 (210),
484 sh (3.5), 522 (15.9), 553 sh (4.3) nm; FABMS:
1228.0 (M+ Anal. Calc. 1228.10), M+ for chloro com-
plex also observed.
diphosphines
Toluene (10 ml) was added to a Schlenk flask and
heated to 105° under a stream of argon. 1,2-Bis(-
diphenylphosphino)ethane (dppe, 32 mg, 0.08 mmol)
was added, followed by Pd2dba3 (18 mg, 0.02 mmol).
The dark purple color of the palladium starting mate-
rial faded rapidly, leaving a clear yellow solution. After
stirring for a further 10 min, H2DPPBr (2) (10.8 mg,
0.02 mmol) was added, and the mixture was stirred at
105° for a further 2.5 h, and the reaction progress was
monitored by TLC using dichloromethane–hexane 1:1
as the eluent. After cooling to room temperature, the
volume was reduced to about one-third under vacuum,
and ether was added to precipitate the product
PdBr(H2DPP)(dppe) (10) as dark purple crystals (17
mg, 80%). The crystal structure of this complex was
reported in our preliminary communication [11]. This
method was also used to prepare 11 (heating for 4 h,
70% yield) and 12. For 12, the bromoporphyrin was
consumed within 40 min, and the product precipitated
directly from the hot reaction mixture. A 60% yield of
12 was obtained by cooling, collecting the brown pow-
der, washing with cold toluene (2 ml), then hexane (2
ml), and vacuum drying.
1
Data for 7: H-NMR (C6D6): l −2.61 (2H, br s,
NH), 6.2–6.4 (18H, m, M), 7.5–7.7 (18H, m, PPh and
m-, p-10,20-Ph), 8.17 (4H, dd, o-10,20-Ph), 8.72 (2H, d,
b-H), 9.08 (4H, br s, 2×b-H), 9.85 (1H, s, meso-H),
10.28 (2H, d, b-H); 31P-NMR (C6D6): l 29.7; UV–vis:
umax (m/103 M−1 cm−1) 400 sh (70.4), 418 (330), 482
(3.6), 514 (13.7), 550 (10.2), 587 (4.4), 642 (6.3) nm;
FABMS: 1173.0 (MH+ Anal. Calc. 1173.19), MH+ for
chloro complex also observed.
3.2. Syntheses using Pd2(dba)3 and monodentate ligands
As an example of this method, H2DPPBr (2) (5.4 mg,
0.01 mmol) was added to degassed toluene (5 ml) at ca.
105° with stirring. Solid AsPh3 (12 mg, 0.04 mmol) and
then Pd2(dba)3 (9 mg, 0.01 mmol) were added, and
heating and stirring were continued. TLC (elution with
50/50 dichloromethane–hexane) showed completion of
the reaction within 5 min. After 20 min, the toluene was
removed under vacuum, and the residue was triturated
three times with ether. Each time the supernatant was
decanted, then the volatiles were removed under vac-
uum, leaving the product PdBr(H2DPP)(AsPh3)2 (8) as
purple microcrystals. TLC showed the absence of the
starting material. As described above, some exchange
to form the chloro analogue occurred in the presence of
chlorinated solvents. This method was also used to
prepare 6, 7, and 9 (using doubled molar amounts of
Pd(0) and Ph3P for 9, and heating for 40 min in each
case). In the case of 6 and 7, it was shown that the
reaction of all the bromoporphyrin required two equiv-
alents of Pd, i.e. PorꢀBr:Pd2dba3=1:1.
Data for 10: 1H-NMR: l −2.95 (2H, br s, NH), 2.53
(4H, m, PCH2), 6.24 (4H, td, m-PPh on P cis to DPP),
6.48 (4H, dd, o-PPh on P cis to DPP), 6.72 (2H, br t,
p-PPh on P cis to DPP), 7.6–7.8 (12H, m, 10,20-Ph and
PPh on P trans to DPP), 8.05 (2H, br d, PPh on P trans
to DPP), 8.24 (2H, br d, PPh on P trans to DPP),
8.3–8.4 (4H, m, 10,20-Ph), 8.52, 8.87, 9.18, 9.52 (each
2H, d, b-H), 9.94 (1H, s, meso-H); 31P-NMR: l 42.6 (d,
JPP 28 Hz), 57.0 (d, JPP 28 Hz); UV–vis: umax (m/103
M−1 cm−1) 397 sh (108), 414 (303), 509 (12.5), 544
(7.5), 580 (5.7), 634 (5.7) nm; FABMS: 1047.1 (MH+
Anal. Calc. 1047.14), MH+ for chloro complex also
observed.
Data for 11: 1H-NMR: l −2.95 (2H, br s, NH), 1.98
(2H, br m, CH2), 2.35–2.5 (4H, br m, PCH2), 5.52 (4H,
td, m-PPh on P cis to DPP), 5.60 (2H, dd, p-PPh on P
cis to DPP), 6.16 (4H, dd, o-PPh on P cis to DPP),
7.55–7.7 (12H, m, 10,20-Ph and PPh on P trans to
DPP), 8.07 (2H, br d, PPh on P trans to DPP), 8.17
(4H, m, 10,20-Ph), 8.29 (2H, br d, PPh on P trans to
1
Data for 8: H-NMR: l −3.41 (2H, br s, NH), 6.4
(18H, m, AsPh), 7.0 (12H, dd, AsPh), 7.7 (6H, m, m-,
p-10,20-Ph), 8.11 (4H, dd, o-10,20-Ph), 8.41, 8.85, 9.14,
9.72 (each 2H, d, b-H), 9.85 (1H, s, meso-H); UV–vis:
umax (m/103 M−1 cm−1) 398 sh (83.0), 416 (319), 480
(4.5), 513 (14.9), 548 (11.0), 586 (4.7), 641 (6.6) nm;